High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients

BackgroundCOVID-19 Convalescent plasma (CCP) is safe and effective, particularly if given at an early stage of the disease. Our study aimed to identify an association between survival and specific antibodies found in CCP.Patients and MethodsPatients ≥18 years of age who were hospitalized with modera...

Full description

Bibliographic Details
Main Authors: Uri Greenbaum, Kimberly Klein, Fernando Martinez, Juhee Song, Peter F. Thall, Jeremy L. Ramdial, Cristina Knape, Fleur M. Aung, Jamie Scroggins, Adriana Knopfelmacher, Victor Mulanovich, Jovan Borjan, Javier Adachi, Mayoora Muthu, Cerena Leung, Mayrin Correa Medina, Richard Champlin, Amanda Olson, Amin Alousi, Katayoun Rezvani, Elizabeth J. Shpall
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-04-01
Series:Frontiers in Immunology
Subjects:
COVID-19
convalescent plasma
coronavirus antibodies
HCoV-OC43
HCoV-HKU1
SARS-CoV-2
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2021.675679/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2021.675679/full

Similar Items